PhRMA has made numerous statements about the IRA negatively impacting innovation. Learn what the seven primary areas of R&D are that are being targeted for reduction.

There is a vital role the biopharmaceutical industry can play in the ongoing debate about health care costs and patient outcomes: developing the rigorous evidence base for policies that impact what patients are experiencing right now.